POSTER: Artificial Intelligence Assisted Macrophage Identification in Tumor Biopsies
BACKGROUND: Understanding response to immunotherapy requires accurate and complete characterization of tumor-associated immune cells in order to fully contextualize the immuno-oncology biomarker expression. Current standard
POSTER: Building Predictive Models Of Clinical Outcomes In Immune Oncology Using Computational Tissue Analysis Scorecards
ABSTRACT Several studies have shown that the location and expression of infiltrating immune cells in patient tumors can better identify which patients are more likely
Pathologists Versus AI
Artificial intelligence (AI) systems for pathology may appear to compete with manual pathology, as they enable the assessment of thousands of cells and application of
CIOReview Names Flagship Company of the Year
CIOReview named Flagship Biosciences “Company of the Year,” as part of the publication’s 2018 20 Most Promising Pharma & Life Sciences Tech Solution Providers industry
POSTER: Using Artificial Intelligence to Predict Response to Immunotherapy
Key Concepts: Pathological interpretations applied to PD-L1 IHC as a response biomarker are becoming more complex, going beyond simple tumor proportion score (TPS) and requiring
POSTER: Pathology AI (Artificial Intelligence)
Deep learning has created a hype about artificial intelligence (AI) and healthcare AI. Flagship Biosciences has been developing a pathology AI system over the last
